Anti-myeloma mechanisms of the selective NF-κB inhibitor QNZ.
- DOI
- 10.1016/j.omton.2026.201267
- Published
- 2026 Sep 17
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2026.201267,
title = {Anti-myeloma mechanisms of the selective NF-κB inhibitor QNZ.},
author = {Cholujova D and Valuskova Z and Burikova M and Hucko M and Beke G and Sedlackova E and Klucar L and Suroviakova K and Grofova G and Sedlak J and Jakubikova J},
year = {2026},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2026.201267},
url = {https://doi.org/10.1016/j.omton.2026.201267}
}RIS
TY - JOUR TI - Anti-myeloma mechanisms of the selective NF-κB inhibitor QNZ. AU - Cholujova D AU - Valuskova Z AU - Burikova M AU - Hucko M AU - Beke G AU - Sedlackova E AU - Klucar L AU - Suroviakova K AU - Grofova G AU - Sedlak J AU - Jakubikova J PY - 2026 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2026.201267 UR - https://doi.org/10.1016/j.omton.2026.201267 ER -
APA
D, C., Z, V., M, B., M, H., G, B., E, S., L, K., K, S., G, G., J, S., & J, J. (2026). Anti-myeloma mechanisms of the selective NF-κB inhibitor QNZ.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201267
Source records
- pubmed · retrieved 2026-09-27T07:48:05.163Z